Max Bayer – Page 11 – Endpoints News

about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Gilead shells out $320M to J&J to buy out rare liver disease drug royalties

9 months ago

Apellis and Sobi land another late-stage win for rare kidney disease drug

9 months ago

Inspection delays hold back BeiGene's Tevimbra progress once again

9 months ago

Updated: Amgen's Horizon buyout powers growth, with MariTide plans intact

9 months ago

CDC chief says new RSV guidance was meant to be ‘clear’ and ‘actionable’

9 months ago

GSK wins second Zantac cancer case to go to trial

9 months ago

BioCryst culls Factor D inhibitor; Elevation Oncology’s stock plummets

9 months ago

Nuvation pauses BET inhibitor plans after checking out interim Phase 1 data

9 months ago

Bristol Myers to cut more jobs at headquarters as part of announced restructure

9 months ago

Q&A: Genentech's new CEO on AI, IRA and radiopharma

9 months ago

Vir's overhaul brings an end to most virology work — and a beginning with cancer

9 months ago

Despite recent trial success, uniQure plans to cut 65% of staff

9 months ago

Arbutus reduces headcount after axing HBV combo trial that features Imfinzi

9 months ago

It took more than two decades for MDMA to reach the FDA. In two months, its prospects cracked. What happens next?

9 months ago

Sanofi sues Sarepta, alleging that Duchenne treatment Elevidys infringes on AAV patents

9 months ago

Biosecure lawmakers tell trade groups that China studies are a new focus

9 months ago

China corruption crackdown hits Merck’s Gardasil sales, spooking investors

9 months ago

Keytruda tops $7B quarterly sales for the first time

9 months ago

NewAmsterdam succeeds in the first of three key pivotal studies, providing hope to a troubled cardio class

10 months ago

Among pharma CEOs, the IRA now and the IRA later get very different reactions

10 months ago

EU panel follows FDA’s lead on Wegovy, recommending use to prevent cardiac events

10 months ago

Sanofi shelves four assets, including mid-stage dwarfism candidate

10 months ago

BioMarin snags expanded Brineura label, now approved for all kids regardless of symptoms

10 months ago

US bankrolls a third of global Pandemic Fund. Can it get congressional support?

10 months ago

First page Previous page 8 9 101112 13 14 Next page Last page